Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
about
Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@en
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@nl
type
label
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@en
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@nl
prefLabel
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@en
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@nl
P2093
P2860
P356
P1476
Combined Anti-CD154/CTLA4Ig Co ...... Osteomyocutaneous Allografts.
@en
P2093
G Brandacher
J A Zelken
M R Anggelia
P2860
P304
P356
10.1111/AJT.13694
P407
P577
2016-02-23T00:00:00Z